Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure
- Tett, Susan E.
- Saint-Marcoux, Franck
- Staatz, Christine E.
- Brunet, Merce
- Vinks, Alexander A.
- Miura, Masatomo
- Marquet, Pierre
- Kuypers, Dirk R.
- van Gelder, Teun
- Cattaneo, Dario
Publication date
April 2011
DOI Publisher
Elsevier BV ISSN
0955-470X Citation count (estimate)
49Abstract
This article summarizes part of a consensus meeting about mycophenolate (MPA) therapeutic drug monitoring held in Rome under the auspices of The Transplantation Society in November 2008 (Clin J Am Soc Nephrol. 2010;5:341-358). This part of the meeting focused on the clinical pharmacokinetics of MPA and included discussion on how to measure MPA (active drug) exposure and the differences between the currently available formulations
Add to ORKG